TP Miller
Impact in
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment
- Oncology top 1%
- Drug Transport and Resistance Mechanisms
- Viral-associated cancers and disorders
Papers in
-
- Lymphoma Diagnosis and Treatment 19
- Oncology 17
- Drug Transport and Resistance Mechanisms 4
- Viral-associated cancers and disorders 4
- Cancer Treatment and Pharmacology 3
- Co-authors
- TM Grogan (12 shared papers)CM Spier (8 shared papers)Thomas M. Grogan (4 shared papers)William S. Dalton (2 shared papers)BN Nathwani (5 shared papers)SE Jones (2 shared papers)Catherine Spier (3 shared papers)Steve Dahlberg (4 shared papers)
- Journals
- Blood (15 papers)Journal of Clinical Oncology (8 papers)Journal of Clinical Investigation (1 paper)Anti-Cancer Drugs (1 paper)Haematologica (1 paper)
- Partner nations
- United StatesMalaysia
In The Last Decade
TP Miller
28 papers receiving 3.2k citations
TP Miller's Hit Papers
Peers
Comparison fields: 5 of 77
- Pathology and Forensic Medicine 1.7k
- Oncology 1.7k
- Genetics 576
- Neurology 402
- Dermatology 181
Countries citing papers authored by TP Miller
This map shows the geographic impact of TP Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by TP Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites TP Miller more than expected).
Fields of papers citing papers by TP Miller
This network shows the impact of papers produced by TP Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by TP Miller. The network helps show where TP Miller may publish in the future.
Co-authors
The 25 scholars most cited alongside TP Miller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy. Hit paper breakdown → | 1989 | 478 |
| 2 | 1991 | 328 | |
| 3 | 1986 | 300 | |
| 4 | 1995 | 239 | |
| 5 | 1994 | 205 | |
| 6 | 1991 | 195 | |
| 7 | 1988 | 190 | |
| 8 | 1992 | 183 | |
| 9 | 1994 | 174 | |
| 10 | 1983 | 162 | |
| 11 | 1992 | 139 | |
| 12 | 1988 | 111 | |
| 13 | 1988 | 84 | |
| 14 | 1988 | 82 | |
| 15 | 1986 | 67 | |
| 16 | 1987 | 67 | |
| 17 | Tumor-infiltrating T-lymphocytes in B-cell diffuse large cell lymphoma related to disease course. | 1990 | 52 |
| 18 | 2012 | 51 | |
| 19 | 1991 | 45 | |
| 20 | 1983 | 37 |
About TP Miller
TP Miller is a scholar working on Pathology and Forensic Medicine, Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 28 papers that have together received 3.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (19 papers), Drug Transport and Resistance Mechanisms (4 papers), Viral-associated cancers and disorders (4 papers), Cancer therapeutics and mechanisms (4 papers), Cutaneous lymphoproliferative disorders research (4 papers), Chronic Lymphocytic Leukemia Research (4 papers), Cancer Treatment and Pharmacology (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.7k citations), Oncology (1.7k citations), Genetics (576 citations), Neurology (402 citations) and Dermatology (181 citations). TP Miller has collaborated with scholars based in United States and Malaysia. Frequent co-authors include TM Grogan, CM Spier, Thomas M. Grogan, William S. Dalton, BN Nathwani, SE Jones, Catherine Spier, Steve Dahlberg, Lippman Sm and Charles W. Taylor. Their work appears in journals such as Blood, Journal of Clinical Oncology, Journal of Clinical Investigation, Anti-Cancer Drugs and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.